Kneat.com Inc T.KSI

Alternate Symbol(s): KSIOF

Healthcare Medical Devices

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.

TSX:KSI - Post by User

Kneat.com Inc

Bullboard Posts

Comment by Empire82on Mar 19, 2019 9:42pm

76 Views

Post# 29508811

RE:Target Price

avenueman wrote: I think two analysts have a 12 month target over $3. I think this target could be conservative.

Mackie has a 2.50 target based on 7x 2022 sales of 20 million, which is in line with what other SAAS companies are valued at. This however doesn't reflect any new contracts signed and they just signed another one a few days ago so yes KSI will more than likely be headed to mulitple dollars in the coming years as they continue to execute

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale